CHECKMATE PHARMACEUTICALS IN (CMPI)
US1628181083 - Common Stock
CHECKMATE PHARMACEUTICALS IN
NASDAQ:CMPI (5/27/2022, 7:00:01 PM)
10.5
+0.02 (+0.19%)
Company Profile
Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The company is headquartered in Cambridge, Massachusetts and currently employs 30 full-time employees. The company went IPO on 2020-08-07. The firm's product candidate, vidutolimod (CMP-001), is an advanced generation Toll-like receptor 9 (TLR9) agonist, delivered as a biologic virus-like particle (VLP) utilizing a CpG-A oligodeoxynucleotide as a key component, designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The firm is conducting a Phase II trial of vidutolimod in combination with nivolumab (OPDIVO), in anti-PD-1 refractory melanoma. The firm is also conducting a randomized Phase II/III trial of vidutolimod in combination with nivolumab in first-line melanoma. The firm's VLP technology is designed to encapsulate and protect the CpG-A oligonucleotide from degradation in the tumor.
Company Info
CHECKMATE PHARMACEUTICALS IN
245 Main Street, 2Nd Floor
Cambridge MASSACHUSETTS 02142
P: 19785032124.0
CEO: Barry Labinger
Employees: 30
Website: http://checkmatepharma.com/
CMPI News
CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology...
2 years ago - Kahn Swick & Foti, LLCCHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPICAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical...
2 years ago - Weiss LawSHAREHOLDER ALERT: Weiss Law Reminds FSI, NTUS, ACC, and CMPI Shareholders About Its Ongoing Investigations/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
2 years ago - Kahn Swick & Foti, LLCCHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI2 years ago - Weiss LawSHAREHOLDER ALERT: Weiss Law Reminds FSI, NTUS, ACC, and CMPI Shareholders About Its Ongoing Investigations/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
CMPI Twits
Here you can normally see the latest stock twits on CMPI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
